AMN Healthcare Services (AMN) Q2 2024 earnings summary

Executive summary

• Q2 2024 revenue was $741 million, down 25% year-over-year and 10% sequentially, with net income of $16.2 million and adjusted EPS of $0.98, both significantly lower than last year.

• Earnings exceeded margin guidance due to strong expense management and favorable SG&A items, despite declines across all segments.

• Technology investments, brand consolidation, and operational reorganization are driving competitive positioning and efficiency; Technology and Workforce Solutions contributed 41% of operating income, with language services revenue up 18%.

• ShiftWise Flex now manages over half of vendor-neutral spend and recently won a multiyear public sector contract; first MSP client migrations completed.

• Largest clients continue to reduce contingent labor spend, but there are signs of improvement in the travel nurse market.

Financial highlights

• Q2 revenue was $741 million, down 25% year-over-year and 10% sequentially, with net income of $16 million and adjusted EBITDA of $94 million (12.7% margin), both down sharply year-over-year.

• Gross margin was 31.0%, down 230 basis points year-over-year, mainly due to lower margins in nurse and allied and technology segments.

• SG&A expenses were $149 million (20.1% of revenue), down from $202 million (20.4%) last year, reflecting lower compensation and prudent expense management.

• Operating cash flow was $100 million in Q2; cash and cash equivalents at quarter end were $48 million, with $1.2 billion in long-term debt and a net leverage ratio of 2.6x.

• Adjusted EPS was $0.98, down from $2.38 prior year and $0.97 prior quarter; diluted EPS for Q2 2024 was $0.42.

Outlook and guidance

• Q3 2024 revenue guidance: $660–$680 million, down 20–23% year-over-year; gross margin expected at 30.7–31.2%; SG&A at 22–22.5% of revenue; operating margin 2.1–2.9%; adjusted EBITDA margin 10.6–11.1%.

• Nurse and Allied Q3 revenue expected down 32–34% year-over-year, but improved from H1; Physician and Leadership Solutions Q3 revenue projected up 12–14%; Technology and Workforce Solutions Q3 revenue down 10–12%.

• Bill rates for Nurse and Allied expected down low single digits sequentially in Q3; volumes down low double digits.

• Q3 estimates include $20 million depreciation, $22 million amortization, $15 million interest expense, and a 27%–28% adjusted tax rate.

• Cash from operations and available credit are expected to be sufficient for liquidity needs over the next 12 months and beyond.